Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ohtake

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry|May 20, 2000
Discovery of a muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors among 2-[(1S,3S)-3-sulfonylaminocyclopentyl]phenylacetamide derivativesM Mitsuya, Y Ogino, K Kawakami, et al.
Gastroenterology|January 29, 2000
Genipin, a metabolite derived from the herbal medicine Inchin-ko-to, and suppression of Fas-induced lethal liver apoptosis in miceM Yamamoto, N Miura, N Ohtake, et al.
Bioorganic & Medicinal Chemistry|September 8, 1998
Novel dithiocarbamate carbapenems with anti-MRSA activityN Ohtake, H Imamura, H Jona, et al.
The Tohoku Journal of Experimental Medicine|June 2, 1998
Significance of measurement of prostate specific antigen (PSA) in familial prostate cancer linesN Ohtake, S Nakata, J Sato, et al.
International Journal of Immunopharmacology|March 23, 2000
Modulation of lung local immune responses by oral administration of a herbal medicine Sho-saiko-toN Ohtake, R Suzuki, H Daikuhara, et al.
The British Journal of Dermatology|May 20, 2003
Novel mutations in GJB2 encoding connexin-26 in Japanese patients with keratitis-ichthyosis-deafness syndromeS Yotsumoto, T Hashiguchi, X Chen, et al.
Bioorganic & Medicinal Chemistry|January 13, 2000
J-104129, a novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptorsM Mitsuya, T Mase, Y Tsuchiya, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 26, 1998
Familial prostate cancer in four brothersN Ohtake, S Nakata, M Hatori, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 17, 2001
Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activityH Hirose, I Aoki, T Kimura, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2000
Structure-activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Part 2: J-111,225, J-114,870, J-114,871 and related compoundsH Imamura, N Ohtake, A Shimizu, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry|May 20, 2000
Discovery of a muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors among 2-[(1S,3S)-3-sulfonylaminocyclopentyl]phenylacetamide derivativesM Mitsuya, Y Ogino, K Kawakami, et al.
Gastroenterology|January 29, 2000
Genipin, a metabolite derived from the herbal medicine Inchin-ko-to, and suppression of Fas-induced lethal liver apoptosis in miceM Yamamoto, N Miura, N Ohtake, et al.
Bioorganic & Medicinal Chemistry|September 8, 1998
Novel dithiocarbamate carbapenems with anti-MRSA activityN Ohtake, H Imamura, H Jona, et al.
The Tohoku Journal of Experimental Medicine|June 2, 1998
Significance of measurement of prostate specific antigen (PSA) in familial prostate cancer linesN Ohtake, S Nakata, J Sato, et al.
International Journal of Immunopharmacology|March 23, 2000
Modulation of lung local immune responses by oral administration of a herbal medicine Sho-saiko-toN Ohtake, R Suzuki, H Daikuhara, et al.
The British Journal of Dermatology|May 20, 2003
Novel mutations in GJB2 encoding connexin-26 in Japanese patients with keratitis-ichthyosis-deafness syndromeS Yotsumoto, T Hashiguchi, X Chen, et al.
Bioorganic & Medicinal Chemistry|January 13, 2000
J-104129, a novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptorsM Mitsuya, T Mase, Y Tsuchiya, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 26, 1998
Familial prostate cancer in four brothersN Ohtake, S Nakata, M Hatori, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 17, 2001
Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activityH Hirose, I Aoki, T Kimura, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2000
Structure-activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Part 2: J-111,225, J-114,870, J-114,871 and related compoundsH Imamura, N Ohtake, A Shimizu, et al.
Pageof 9